| Sr. No | Title of Research Project | Name of Principle Investigator | Sanctioning/ Collaborating Agency | Completed/Ongoing |
| 1 | Clinical trial- A randomized, open label, two way crossover study to compare inhalation flow profiles generated with medication free generic tiotropium bromide inhalation device of Cipla Ltd, India and SPIRIVA HANDIHALER device of Boehringer ingelheim pharmaceuticals, inc, USA in healthy adult subjects and adult subjects with moderate, sever and very severe chronic obstructive pulmonary disease (Crd/27)(the clinical study) | Dr. Gauri Kulkarni | Cipla ltd | Ongoing |
- Research activity of Department:
| Sr. No. | Year | Title of the Research | Name | Status |
| 1 | 2018-2019 | Outcome of multidrug Resistant Tuberculosis 5yr follow up study | Dr. Gauri Kulkarni
Dr. Nilesh Patil |
Completed |
| 2 | 2018-2020 | To Study Respiratory Manifestation in chronic Renal Failure Patients | Dr. G. S. Kulkarni
Dr. Nikhil Raj |
Ongoing |
| 3 | 2018-2020 | Study of Clinical Profile H1 N1 Swine flu influenza patients at a tertiary care center | Dr. R. M. Sundrani
Dr. G. S. Kulkarni Dr. Jaspreet Singh |
Ongoing |
| 4 | 2019 | Study of Adverse Drug reactions Related to Pre XDR and XDR Tuberculosis on Bedaquline Drug within 14 days of Admission | Dr. S. R. Dugad | Completed |
| 5 | 2020 | Clinical Characteristics of Covid 19 (Sars-Cov-2) Patients at a Tertiary Health Care Centre | Dr. G. S. Kulkarni
Dr. Ravindra Shinde Dr. Chaitanya Kappagantu |
Ongoing |
| 6 | 2020 | Clinicoradiological Corelation In Covid 19 (Sars-Cov-2) Patients Admitted at Aa Tertiary Health Care Centre” | Dr. Ravindra Shinde
Dr. Gauri Kulkanri Dr. Jaspreet Singh |
Ongoing |
| 7 | 2020 | Role of HCQ chemoprophylaxis on clinical profile of COVID 19 patients. | Dr. Sushama Dugad
Dr. Nikhil Raj |
ongoing |
| 8 | 2020 | Clinical characteristics of asymptomatic patients of COVID 19 patients admitted in tertiary health care centre | Dr. Sushama Dugad
Dr. Siddhesh Bharadi |
ongoing |